Profusa, Inc. Common Stock (PFSA)
Profusa, Inc. Common Stock operates in the Medical - Devices industry of the Healthcare sector, headquartered in Berkeley, CA, US. The stock last traded at $1.92, up 0.52% on the session, giving a market capitalisation of $2.1M. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of 0.0%. Its beta of 0.47 implies it has historically moved less than the broad market.
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Profusa, Inc. Common Stock is most often compared with the following Healthcare names: